Australia markets close in 8 minutes

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
274.06+4.31 (+1.60%)
At close: 04:00PM EDT
274.06 0.00 (0.00%)
After hours: 07:31PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close269.75
Open270.00
Bid0.00 x 1200
Ask0.00 x 3000
Day's range268.33 - 279.70
52-week range261.59 - 468.45
Volume371,353
Avg. volume211,131
Market cap7.846B
Beta (5Y monthly)0.88
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference

    HERCULES, Calif., May 01, 2024--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Operating Officer Andy Last and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024, at 2:05 PM Eastern Time (11:05 AM Pacific Time).

  • Business Wire

    Bio-Rad Announces Life Science Group Management Changes

    HERCULES, Calif., April 26, 2024--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the promotion of James J. Barry, currently Senior Vice President of Global Manufacturing, to the position of Executive Vice President and President of the Life Science Group, effective May 1, 2024. He succeeds Dr. Simon May, who has announced his decision to leave the company to pursue another professional opportunity.

  • Business Wire

    Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024

    HERCULES, Calif., April 18, 2024--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2024 on Tuesday, May 7, 2024, following the close of the market. Management will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.